ARTICLE | Clinical News
Angeliq oral once-daily estradiol and drospirenone regulatory update
December 23, 2002 8:00 AM UTC
The Netherlands granted marketing approval to SCH for its Angeliq hormone replacement therapy (HRT) to treat menopausal symptoms and to prevent osteoporosis in women. In October, the FDA issued a non-...